384 related articles for article (PubMed ID: 28615145)
1. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
[TBL] [Abstract][Full Text] [Related]
2. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
3. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
[TBL] [Abstract][Full Text] [Related]
4. Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.
Lyu QQ; Chen QH; Zheng RQ; Yu JQ; Gu XH
J Intensive Care Med; 2020 Oct; 35(10):971-983. PubMed ID: 30270720
[TBL] [Abstract][Full Text] [Related]
5. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
[TBL] [Abstract][Full Text] [Related]
7. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
Valoor HT; Singhi S; Jayashree M
Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
[TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
9. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
10. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
[TBL] [Abstract][Full Text] [Related]
11. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock.
Venkatesh B; Myburgh J; Finfer S; Webb SA; Cohen J; Bellomo R; McArthur C; Joyce CJ; Rajbhandari D; Glass P; Harward M;
Crit Care Resusc; 2013 Jun; 15(2):83-8. PubMed ID: 23931038
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study.
Coloretti I; Biagioni E; Venturelli S; Munari E; Tosi M; Roat E; Brugioni L; Gelmini R; Venturelli C; Girardis M
J Crit Care; 2020 Oct; 59():37-41. PubMed ID: 32512351
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
[TBL] [Abstract][Full Text] [Related]
14. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
15. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial.
Lyu QQ; Zheng RQ; Chen QH; Yu JQ; Shao J; Gu XH
Crit Care; 2022 Sep; 26(1):295. PubMed ID: 36171582
[TBL] [Abstract][Full Text] [Related]
16. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*.
Katsenos CS; Antonopoulou AN; Apostolidou EN; Ioakeimidou A; Kalpakou GT; Papanikolaou MN; Pistiki AC; Mpalla MC; Paraschos MD; Patrani MA; Pratikaki ME; Retsas TA; Savva AA; Vassiliagkou SD; Lekkou AA; Dimopoulou I; Routsi C; Mandragos KE;
Crit Care Med; 2014 Jul; 42(7):1651-7. PubMed ID: 24674923
[TBL] [Abstract][Full Text] [Related]
17. Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A
Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600
[TBL] [Abstract][Full Text] [Related]
18. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.
Oppert M; Reinicke A; Gräf KJ; Barckow D; Frei U; Eckardt KU
Intensive Care Med; 2000 Dec; 26(12):1747-55. PubMed ID: 11271081
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
[TBL] [Abstract][Full Text] [Related]
20. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.
Annane D; Sébille V; Bellissant E;
Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]